Morning Market Movers
July 09, 2013 at 09:56 AM EDT
CytRx (NASDAQ: CYTR ) rose 29.55% to 2.85 after the company reported that aldoxorubicin demonstrated statistically significant efficacy in the treatment of rapidly growing human brain cancer brains animals. The Dolan Company (NYSE: DM ) shares jumped 16.67% to $2.07 after the company announced its plans to sell two
